Furosemidum [Inn-Latin] en es it fr

Furosemidum [Inn-Latin] Brand names, Furosemidum [Inn-Latin] Analogs

Furosemidum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Furosemidum [Inn-Latin] Chemical_Formula

C12H11ClN2O5S

Furosemidum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/furos.htm

Furosemidum [Inn-Latin] fda sheet

Furosemidum_[Inn-Latin] FDA

Furosemidum [Inn-Latin] msds (material safety sheet)

Furosemidum_[Inn-Latin] MSDS

Furosemidum [Inn-Latin] Synthesis Reference

K. Sturm et al., U.S. Pat. 3,058,882 (1962)

Furosemidum [Inn-Latin] Molecular Weight

330.745 g/mol

Furosemidum [Inn-Latin] Melting Point

206 oC

Furosemidum [Inn-Latin] H2O Solubility

0.006 mg/mL

Furosemidum [Inn-Latin] State

Solid

Furosemidum [Inn-Latin] LogP

1.514

Furosemidum [Inn-Latin] Dosage Forms

Tablet

Furosemidum [Inn-Latin] Indication

For the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Also for the treatment of hypertension alone or in combination with other antihypertensive agents.

Furosemidum [Inn-Latin] Pharmacology

Furosemide, a sulfonamide-type loop diuretic structurally related to bumetanide, is used to manage hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome.

Furosemidum [Inn-Latin] Absorption

No information avaliable

Furosemidum [Inn-Latin] side effects and Toxicity

No information avaliable

Furosemidum [Inn-Latin] Patient Information

Furosemidum [Inn-Latin] Organisms Affected

Humans and other mammals